Drugs: psychiatry

You have access
Benzodiazepine receptor agonist dispensations in Alberta: a population-based descriptive study
Daniala L. Weir, Salim Samanani, Fizza Gilani, Ed Jess and Dean T. Eurich

December 27, 2018 6 (4) E678-E684; DOI: https://doi.org/10.9778/cmajo.20180121
You have access
The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians
Martina Kelly, Tim Dornan and Tamara Pringsheim

April 30, 2018 6 (2) E191-E196; DOI: https://doi.org/10.9778/cmajo.20170145
You have access
The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
Michael R. Law, Lucy Cheng, Ashra Kolhatkar, Laurie J. Goldsmith, Steven G. Morgan, Anne M. Holbrook and Irfan A. Dhalla

February 13, 2018 6 (1) E63-E70; DOI: https://doi.org/10.9778/cmajo.20180008
You have access
Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study
Tamara Pringsheim and David M. Gardner

October 07, 2014 2 (4) E225-E232; DOI: https://doi.org/10.9778/cmajo.20140009
You have access
Use of benzodiazepines and related drugs in Manitoba: a population-based study
Silvia Alessi-Severini, James M. Bolton, Murray W. Enns, Matthew Dahl, David M. Collins, Dan Chateau and Jitender Sareen

October 01, 2014 2 (4) E208-E216; DOI: https://doi.org/10.9778/cmajo.20130076

Main menu